Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Histone H3K27M variants determine myeloid subset dependencies and immune reprogramming in diffuse midline glioma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 13, 2026
Targeting an RNA Editor to Impede H3K27M+ Pediatric Gliomas.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.
Journal: Neuro-oncology
Published: February 13, 2026
Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.
Journal: Journal of neuro-oncology
Published: November 28, 2025
Multi-Course Reirradiation in Diffuse Intrinsic Pontine Glioma.
Journal: Practical radiation oncology
Published: August 21, 2025
Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma.
Journal: Neuro-oncology advances
Published: July 23, 2025
Challenging the Odds: Long-Term Survival in Pediatric Diffuse Midline Glioma With H3 K27M and BRAF V600 Co-Mutations Treated With Upfront Radiotherapy and Targeted Therapy.
Journal: Pediatric blood & cancer
Published: May 05, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon.
Journal: NPJ precision oncology
Published: April 28, 2025
A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 13, 2025
IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas.
Journal: Acta neuropathologica communications
Published: November 05, 2024
Last Updated: 09/26/2026